Role of probiotics in the modulation of intestinal infections and inflammation

Current Opinion in Gastroenterology

Volumn 20, Issue 1, 2004, Pages 22-26

  Mack, David R ^a   Lebel, Sylvie ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Adherence; Antibiotic associated diarrhea; Apoptosis; Bifidobacterium; Gastroenteritis; Heat killed; Lactobacillus; Mucin

Indexed keywords

PROBIOTIC AGENT;

CELL SURVIVAL; CLINICAL TRIAL; COLONY FORMING UNIT; DIARRHEA; EUKARYOTIC CELL; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; INTESTINE MUCOSA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PATHOGENESIS; REVIEW;

EID: 3843138944     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200401000-00006     Document Type: Review

References (37)

1. Mack DR, Michail S, Wei S, et al.: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999, 276:G941-G950.
2. Michail S, Abernathy F: Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr 2002, 35:350-355.
3. Michail S, Abernathy F: Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr 2003, 36:385-391.
4. Van Niel CW, Feudtner C, Garrison MM, et al.: Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002, 109:678-684. Nine randomized, blinded, placebo-controlled trials were included in this meta-analysis showing benefit for strains of Lactobacillus for therapy of acute gastroenteritis. A subanalysis showed a direct dose-effect relationship.
5. Rosenfeldt V, Michaelsen KF, Jakobsen M, et al.: Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J 2002, 21:417-419. This study evaluated the benefit of administration of a blend of two Lactobacillus strains for acute gastroenteritis in children from a day care setting. The probiotic mixture was demonstrated to be most effective when given earlier in the course of diarrhea.
6. Costa-Ribeiro H, Ribeiro TCM, Mattos AP, et al.: Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr 2003, 36:112-115.
7. D'Souza AL, Rajkumar C, Cooke J, et al.: Probioticsin prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002, 324:1361-1366. Nine trials were included in this meta-analysis, which yielded evidence that probiotics may be useful in the prevention of antibiotic-associated diarrhea. Comparison of four Saccharomyces boulardii trials with the bacterial probiotic trials showed similar benefit.
8. Cremonini F, Di Carlo S, Nista EC, et al.: Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002, 16:1461-1467. Seven trials were included in this meta-analysis on the prevention of antibiotic-associated diarrhea. The determined benefit of probiotics in administration in this meta-analysis is similar to that in [7•].
9. Sheu BS, Wu JJ, Lo CY, et al.: Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002, 16:1669-1675. H. pylori eradication rates comparing patients that did or did not receive a probiotic-containing yogurt in addition to standard triple therapy both showed good effect. However, intention-to-treat analysis showed a greater eradication rate in the triple therapy yogurt group.
10. Kohler H, Rodrigues SP, Maurelli AT, et al.: Inhibition of Salmonella typhimurium enteropathogenicity by piperidine, a metabolite of the polyamine cadaverine. J Infect Dis 2002, 186:1122-1130.
11. Mack DR, Ahrne S, Hyde L, et al.: Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003, 52:827-833. Selected Lactobacillus strains were demonstrated to upregulate mucin gene expression, with secreted mucin expression paralleling gene expression. The ability to adhere to intestinal epithelial cells correlated with the capacity to modulate the gene expression.
12. Rojas M, Ascencio F, Conway PL: Purification and characterization of a surface protein from Lactobacillus fermentum 104R that binds to porcine small intestinal mucus and gastric mucin. Appl Environ Microbiol 2002, 68:2330-2336.
13. Roos S, Jonsson H: A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres to mucus components. Microbiology 2002, 148:433-442.
14. Barrangou R, Altermann E, Hutkins R, et al.: Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus. Proc Natl Acad Sci U S A 2003, 100:8957-8962.
15. Mangell P, Nejdfors P, Wang M, et al.: Lactobacillus plantarum 299v inhibits Escherichia coli-induced permeability. Dig Dis Sci 2002, 47:511-516.
16. Ibnou-Zekri N, Blum S, Schiffrin EJ, et al.: Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 2003, 71:428-436.
17. Agarwal R, Sharma N, Chaudhry R, et al.: Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr 2003, 36:397-402.
18. Dani C, Biadaioli R, Bertini G, et al.: Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. Biol Neonate 2002, 82:103-108.
19. Banasaz M, Norin E, Holma R, et al.: Increased enterocytes production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol 2002, 68:3031-3034. Morphologic comparison of the intestines of germ-free rats with germ-free rats given Lactobacillus GG and conventional rats showed evidence for activity in cell proliferation and morphologic changes of villi and crypts.
20. Yan F, Polk DB: Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002, 277:50959-50965. Selected live, viable, but not heat-killed Lactobacillus prevented cytokine-induced apoptosis. Supernatants from the bacterial cultures were capable of the same effect.
21. Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind placebo-controlled trial. Gastroenterology 2003, 124:1202-1209. Prevention of the development of pouchitis was demonstrated in patients receiving a blend of probiotics.
22. Gionchetti P, Rizzello F, Venturi A, et al.: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:305-309.
23. Kuisma J, Mentula S, Jarvinen H, et al.: Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 2003, 17:509-515.
24. Prantera C, Scribano ML, Falasco G, et al.: Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomized controlled trial with Lactobacillus GG. Gut 2002, 51:405-409.
25. Dieleman LA, Goerres MS, Arends A, et al.: Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 2003, 52:370-376.
26. Borreul N, Carol M, Casellas F, et al.: Increased mucosal tumor necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002, 51:659-664. Explants of Crohn disease tissue incubated with selected Lactobacillus strains induced increased expression of TNF-α.
27. Olah A, Belagyi T, Issekutz A, et al.: Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002, 89:1103-1107.
28. Rayes N, Seehofer D, Hansen S, et al.: Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplantation recipients. Transplantation 2002, 74:123-128.
29. Kirjavainen PV, Salminen SJ, Isolauri E: Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003, 36:223-227. This trial comparing formula without probiotics added to formula with either live or heat-killed Lactobacillus GG was prematurely terminated and code broken after complaints of adverse gastrointestinal symptoms were reported. Only subjects in the heat-inactivated group were found to have developed diarrhea days to weeks after the introduction of formula.
30. Korhonen R, Korpela R, Moilanen E: Signaling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid. Inflammation 2002, 26:207-214.
31. Matsuguchi T, Takagi A, Matsuzaki T, et al.: Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor-inducing activities in macrophages through Toll-like receptor 2. Clin Diag Lab Immunol 2003, 10:259-266.
32. Karlsson H, Hessle C, Rudin A: Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 2002, 70:6688-6696.
33. Pena JA, Versalovic J: Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 2003, 5:277-285.
34. Christensen HR, Frokiaer H, Pestka JJ: Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002, 168:171-178.
35. Salminen MK, Tynkkynen S, Rautelin H, et al.: Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus GG in Finland. Clin Infect Dis 2002, 35:1155-1160.
36. Lammers KM, Helwig U, Swennen SF, et al.: Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 2002, 97:1182-1186.
37. Vidal K, Donnet-Highes A, Granato D: Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect Immun 2002, 70:2057-2064. This in vitro study showed that lipoteichoic acid may have lipopolysaccharide- antagonizing activity for interleukin-8 secretion from an intestinal cell line. Remarks regarding the effect of lipoteichoic acid on peripheral mononuclear cells reveal that cell source is crucial for interpretation of results.